Geode Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Geode Capital Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-996	Closed	-$14K	–	4836
2022 Q4	$14K	Hold	996	–	–	﹤0.01%	4812
2022 Q3	$23K	Hold	996	–	–	﹤0.01%	4900
2022 Q2	$19K	Hold	996	–	–	﹤0.01%	4932
2022 Q1	$35K	Hold	996	–	–	﹤0.01%	4876
2021 Q4	$44K	Sell	996 -3,545	-78%	-$213K	﹤0.01%	4881
2021 Q3	$323K	Buy	4,541 +1,165	+35%	+$133K	﹤0.01%	4235
2021 Q2	$445K	Buy	3,376 +2,850	+542%	+$356K	﹤0.01%	3997
2021 Q1	$70K	Buy	+526	New	+$66.6K	﹤0.01%	4359

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Geode Capital Management's ASLN Position: Q1 2023 in Review

Geode Capital Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2023, closing a stake of 996 shares — an estimated $14K sold.

Geode Capital Management first reported a position in ASLN in Q1 2021 and held it in 8 quarters. The position peaked at $445K in Q2 2021. 16 funds tracked by Wall St. Rank hold ASLN as of Q1 2023.

Geode Capital Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Geode Capital Management sold 996 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2023, an estimated $14K.
Geode Capital Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 8 quarters.
Geode Capital Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $445K in Q2 2021.
16 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.